𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anti–tumor necrosis factor α therapy and the risk of JC virus infection

✍ Scribed by Jonathan C. P. Roos; Andrew J. K. Ostor

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
57 KB
Volume
54
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Infections and anti–tumor necrosis facto
Infections and anti–tumor necrosis factor α therapy
✍ Todd Ellerin; Robert H. Rubin; Michael E. Weinblatt 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 1 views

disease, 2 with pleural disease, and 1 each with paravertebral, meningeal, genital, bladder, enteric, and bone disease.

Anti–tumor necrosis factor α therapy and
Anti–tumor necrosis factor α therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis
✍ Sebastian Schneeweiss; Soko Setoguchi; Michael E. Weinblatt; Jeffrey N. Katz; Je 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 1 views

## Abstract ## Objective To assess the association between the initiation of anti–tumor necrosis factor α (anti‐TNFα) therapy and the risk of serious bacterial infections in routine care. ## Methods This was a cohort study of patients with rheumatoid arthritis (RA) in whom specific disease‐modif

Anti–tumor necrosis factor α therapy and
Anti–tumor necrosis factor α therapy and the risk of lymphoma in rheumatoid arthritis: No clear answer
✍ Deborah P. M. Symmons; Alan J. Silman 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 50 KB 👁 1 views

The authors are the principal investigators of the British Society of Rheumatology (BSR) Biologics Register. The BSR receives financial support for the Register from the manufacturers of biologic agents currently licensed for use in the treatment of patients with inflammatory rheumatic diseases. The